Similar articles

• Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.

  Babu S. Babu S. Natl Med J India. 2003 May-Jun;16(3):175; author reply 175-6. Natl Med J India. 2003. PMID: 12929872 No abstract available.
• Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.

  Nagral A. Nagral A. Natl Med J India. 2003 May-Jun;16(3):175; author reply 175-6. Natl Med J India. 2003. PMID: 12929871 No abstract available.
• Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries.

  Aggarwal R, Ghoshal UC, Naik SR. Aggarwal R, et al. Natl Med J India. 2002 Nov-Dec;15(6):320-7. Natl Med J India. 2002. PMID: 12540064
• [Medico-economic assessment of the therapeutic management of patients with hepatitis C].

  Loubière S, Rotily M, Moatti JP. Loubière S, et al. Gastroenterol Clin Biol. 2000 Nov;24(11):1047-51. Gastroenterol Clin Biol. 2000. PMID: 11139674 Review. French.
• Interferon-alfa in the treatment of chronic hepatitis B.

  Zhang FK. Zhang FK. Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):337-40. Hepatobiliary Pancreat Dis Int. 2004. PMID: 15313664 Review.